CARBONIC ANHYDRASE INHIBITORS

Course overview

CARBONIC ANHYDRASE INHIBITORS ARE A MEDICATION USED IN THE MANAGEMENT AND TREATMENT OF GLAUCOMA, IDIOPATHIC INTRACRANIAL HYPERTENSION, ALTITUDE SICKNESS, CONGESTIVE HEART FAILURE, AND EPILEPSY, AMONG OTHER DISEASES. CARBONIC ANHYDRASE INHIBITORS ARE CONSIDERED PART OF THE DIURETIC CLASS OF MEDICATIONS. THIS ARTICLE REVIEWS THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR CARBONIC ANHYDRASE INHIBITORS AS VALUABLE AGENTS IN THE TREATMENT OF GLAUCOMA AND IDIOPATHIC INTRACRANIAL HYPERTENSION AS WELL AS OTHER DISORDERS. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS, E.G., OFF-LABEL USES, DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, AND RELEVANT INTERACTIONS PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL HEALTHCARE TEAM IN THE TREATMENT OF PATIENTS WITH GLAUCOMA, IDIOPATHIC INTRACRANIAL HYPERTENSION, AND RELATED CONDITIONS.